About XOStem Biosciences
XOStem Biosciences is a private company based in Irvine, California. It has reported $3,390,151 raised in eight offerings on Form D since June 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Feb 29, 2024 | $378,000of $756K target | 10 | $37,800 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 19, 2023 | Oct 11, 2023 | $30,000of $60,000 target | 1 | $30,000 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 18, 2023 | Aug 31, 2023 | $785,500of $1.5M target | 26 | $30,212 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 28, 2023 | Aug 30, 2023 | $65,000of $130K target | 3 | $21,667 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 29, 2023 | Apr 19, 2023 | $587,000of $1.1M target | 34 | $17,265 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 10, 2023 | Jan 23, 2023 | $350,000of $700K target | 3 | $116K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 7, 2022 | Nov 8, 2022 | $892,000of $1.7M target | 21 | $42,476 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 1, 2020 | Jun 16, 2020 | $302,651fully sold | 8 | $37,831 | EquityRule 504 | Form D ↗ |
| Total, eight offerings | $3,390,151 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on XOStem Biosciences's Form D filed Feb 29, 2024.
Earlier filings also listed Gary Yeoman (director, last listed Oct 2023), Brad Eckenweiler (director, last listed Oct 2023), Richard Johns (executive officer and director, last listed Apr 2023) and John Sanderson (executive officer and director, last listed Jun 2020).